NCT01880489

Brief Summary

The objective is to expand and refine an intervention for transgender women (TW) into a 7-session individual- and group-based intervention that is scalable for community settings to reduce sexual risk and substance use and to increase stigma-coping and risk-buffering behaviors among TW in NYC. The investigators will pilot test the intervention with 20 TW and subsequently, conduct a randomized controlled trial with 240 TW to compare the intervention to a wait list control condition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
143

participants targeted

Target at P25-P50 for not_applicable hiv

Timeline
Completed

Started Jun 2013

Longer than P75 for not_applicable hiv

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2013

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

June 13, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 19, 2013

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 2, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 2, 2017

Completed
Last Updated

August 7, 2018

Status Verified

August 1, 2018

Enrollment Period

4.4 years

First QC Date

June 13, 2013

Last Update Submit

August 3, 2018

Conditions

Keywords

transgender womensexual risksubstance useHIV preventionbehavioral intervention

Outcome Measures

Primary Outcomes (2)

  • Number of Unprotected Sex Acts in the Past 90 Days

    Decreases from Baseline in the Number of Unprotected Sex Acts in the past 90 days at 4 and 8 months

    every 4 months over the course of 8 months

  • Number of Days of Drug Use in the Past 90 Days

    Decreases from Baseline in the Number of Days of Drug Use in the past 90 days at 4 and 8 months

    every 4 months over the course of 8 months

Study Arms (2)

MI + CBST Intervention

EXPERIMENTAL

Seven sessions of Motivational Interviewing and Cognitive Behavioral Skills Training

Behavioral: MI + CBST Intervention

Wait List Control Condition

NO INTERVENTION

Interventions

The intervention focuses on exploring health goals, creating an action plan, learning about the impact stress, stigma, and substance use can have on health, improving personal growth and social support, and connecting with resources. The first two sessions will be primarily Motivational Interviewing and will explore participants' feelings about their sexual risk, substance use, non-medically monitored hormone and silicone use, and any other issues. Group sessions (Sessions 3-6) will incorporate Cognitive Behavioral Skills Training focusing barriers to physical and mental health. The last session will focus on reviewing progress toward health goals, identifying barriers to change, and generating a plan for connection to ongoing care to reach target health goals.

MI + CBST Intervention

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • Identify as a transgender woman (assigned male at birth and currently identify as female)
  • Report 3 or more acts of unprotected anal or vaginal sex in the past 90 days and at least 1 in the past 30 days
  • Report 5 or more days of illicit drug use in the past 90 days and at least 2 in the past 30
  • Provide contact information
  • Reside in the NYC metropolitan area
  • Able to complete a survey in English (Spanish-language assistance can be provided by bilingual staff)
  • Provide informed consent

You may not qualify if:

  • Unstable, serious psychiatric symptoms
  • Current suicidal/homicidal ideation
  • Evidence of gross cognitive impairment
  • Currently enrolled in a drug abuse treatment or enrolled in an HIV risk or drug use intervention study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for HIV/AIDS Educational Studies and Training of Hunter College, CUNY

New York, New York, 10018, United States

Location

MeSH Terms

Conditions

Sexually Transmitted DiseasesSubstance-Related Disorders

Condition Hierarchy (Ancestors)

Communicable DiseasesInfectionsGenital DiseasesUrogenital DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsChemically-Induced DisordersMental Disorders

Study Officials

  • H. Jonathon Rendina, Ph.D.

    Hunter College of City University of New York

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 13, 2013

First Posted

June 19, 2013

Study Start

June 1, 2013

Primary Completion

November 2, 2017

Study Completion

November 2, 2017

Last Updated

August 7, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share

Locations